Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology

Annals of Internal Medicine

Volumn 129, Issue 3, 1998, Pages 182-189

  Villers, Daniel ^a,b   Espaze, Eric ^a,c   Coste Burel, Marianne ^a,c   Giauffret, Frédéric ^a,b   Ninin, Emmanuelle ^a,c   Nicolas, Françoise ^a,b   Richet, Hervé ^a,c  

^a INSTITUT DE BIOLOGIE   (France)

^b HÔTEL DIEU   (France)

^c Lab de Bacteriol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RIBOTYPING; RISK FACTOR;

EID: 0032146682     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-3-199808010-00003     Document Type: Article

References (39)

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.
2. Seifert H, Bouillon B, Schulze A, Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994;15:520-8.
3. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;12:1329-32.
4. Lortholary O, Fagon JY, Hoï AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1995;20:790-6.
5. Horrevorts A, Bergman K, Kollee L, Breuker I, Tjernberg I, Dijkshoorn L. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J Clin Microbiol. 1995;33:1567-72.
6. Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol. 1995;16:92-7.
7. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol. 1987;138:569-78.
8. Dolzani L, Tonin E, Lagatolla C, Prandin L, Monti-Bragadin C. Identification of Acinetobacter isolates in the A. calcoaceticus - A. baumannii complex by restriction analysis of the 165-235 rRNA intergenic-spacer sequences. J Clin Microbiol. 1995;33:1108-13.
9. Soussy O, Cluzel R, Courvalin P. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie. Eur J Clin Microbiol Infect Dis. 1994;13:238-46.
10. Samadpour M, Moseley SL, Lory S. Biotinylated DNA probes for exotoxin A and pilin genes in the differentiation of Pseudomonas aeruginosa strains. J Clin Microbiol. 1988;26:2319-23.
11. Richard P, Le Floch R, Chamoux C, Espaze E, Pannier M, Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis. 1994;170:377-83.
12. Brosius J, Ullrich A, Raker MA, Gray A, Dull TJ, Gutell RR, et al. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal operon of E. coli. Plasmid. 1981;6:112-8.
13. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19:6823-31.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
15. Vila J, Almela M, Jimenez de Anta MT. Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp anitratus strains. J Clin Microbiol. 1989;27:1086-9.
16. Beck-Sagué CM, Jarvis WR, Brook JH, Culver DH, Potts A, Gay E, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol. 1990;192:723-33.
17. Cefai C, Richards J, Gould FK, McPeake P. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect. 1990;15:177-82.
18. Struelens MJ, Carlier E, Maes N, Serruys E, Quint WG, van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprintmg. J Hosp Infect. 1993;25:15-32.
19. Levin AS, Mendes CM, Sinto SI, Sader HS, Scarpitta CR, Rodrigues E, et al. An outbreak of multiresistant Acinetobacter baumannii in a university hospital in Sao Paulo, Brazil. Infect Control Hosp Epidemiol. 1996;17:366-8.
20. Mulin B, Talon D, Viel JF, Vincent C, Leprat R, Thouverez M, et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1995;14:569-76.
21. Dijkshoorn L, Aucken HM, Gerner-Smidt P, Kaufmann ME, Ursing J, Pitt TL. Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol. 1993;31:702-5.
22. Joly-Guillou ML, Bergogne-Berezin E, Vieu JF. A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp. J Hosp Infect. 1990;16:49-58.
23. Kropec A, Hübner J, Daschner FD. Comparison of three typing methods in hospital outbreaks of Acinetobacter calcoaceticus infection. J Hosp Infect. 1993;23:133-41.
24. Traub WH. Acinetobacter baumannii serotyping for delineation of outbreaks of nosocomial cross-infection. J Clin Microbiol. 1989;77:2713-6.
25. Andrews HJ. Acinetobacter bacteriocin typing. J Hosp Infect. 1986;9:169-75.
26. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986;51:873-84.
27. Vaneechoutte M, Elaichouni A, Maquelin K, Claeys G, Van Liederkerke A, Louagie H, et al. Comparison of arbitrarily primed polymerase chain reaction and cell envelope protein electrophoresis for analysis of Adnetobacter baumannii and A. junii outbreaks. Res Microbiol. 1995;146: 457-65.
28. Grundmann H, Schneider C, Tichy HV, Simon R, Klare I, Hartung D, et al. Automated laser fluorescence analysis of randomly amplified polymorphic DNA: a rapid method for investigating nosocomial transmission of Acinetobacter baumannii. J Med Microbiol. 1995;43:446-51.
29. Seifert H, Gerner-Smidt P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol. 1995;33:1402-7.
30. Christie C, Mazon D, Hierholzer W Jr, Patterson JE. Molecular heterogeneity of Acinetobacter baumannii isolates during seasonal increase in prevalence. Infect Control Hosp Epidemiol. 1995;16:590-4.
31. Tjernberg I, Ursing J. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS. 1989;97:596-605.
32. Fung-Tomc JC. Correlation of in vitro and in vivo resistance development to antimicrobial agents. Antimicrobial Newsletter. 1990;7:17-24.
33. Peterson LR, Willard KE, Sinn LM, Fasching CE, Gerding DN. GyrA sequence analysis of Staphylococcus aureus and methicillin-resistant S. aureus strains selected, in vitro, for high-level ciprofloxacin resistance. Diagn Microbiol Infect Dis. 1993;17:97-101.
34. Piddock LJ, Hall MC, Walters RN. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains. J Antimicrob Chemother. 1991;28:185-98.
35. Watanabe M, Kotera Y, Yosue K, Inoue M, Mitsuhashi S. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens. Antimicrob Agents Chemother. 1990;34: 173-5.
36. Rohwedder RW, Bergan T, Thorsteinsson SB, Scholl H. Transintestinal elimination of ciprofloxacin. Diagn Microbiol Infect Dis. 1990;13:127-33.
37. Vance-Bryan K, Quay DR, Rotschafer JC. Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet. 1990;19:434-61.
38. Brumfitt W, Franklin I, Grady D, Hamilton-Miller, Illife A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother. 1984; 26:757-61.
39. Vollaard EJ, Clasener HA, Janssen AJ. Decontamination of the bowel by intravenous administration of pefloxacin. J Antimicrob Chemother. 1990;26: 847-52.